NCT03091452 CArdioSurgEry Atrial Fibrillation Register
| NCT ID | NCT03091452 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stiftung Institut fuer Herzinfarktforschung |
| Condition | Atrial Fibrillation |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2017-01 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2017-01 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
CASE AF aims to describe the reality of medical care of patients in whom atrial fibrillation is treated by cardiac surgical ablation.
Eligibility Criteria
Inclusion Criteria: * Atrial fibrilation * Treated by cardiac surgical ablation Exclusion Criteria: * Patient denies participation
Contact & Investigator
Thorsten Hanke, MD
PRINCIPAL INVESTIGATOR
Asklepios Hamburg Harburg
Frequently Asked Questions
Who can join the NCT03091452 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Atrial Fibrillation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03091452 currently recruiting?
Yes, NCT03091452 is actively recruiting participants. Contact the research team at oezdemir@stiftung-ihf.de for enrollment information.
Where is the NCT03091452 trial being conducted?
This trial is being conducted at München, Germany, Hamburg, Germany, Bad Rothenfelde, Germany.
Who is sponsoring the NCT03091452 clinical trial?
NCT03091452 is sponsored by Stiftung Institut fuer Herzinfarktforschung. The principal investigator is Thorsten Hanke, MD at Asklepios Hamburg Harburg. The trial plans to enroll 2,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.